SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Danimer Scientific, Inc. (DNMR) , forward earnings yield 1,666.67%.
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+157.1%).
- Forward P/E 0.1
- Analyst consensus target $0.90 (+157.1% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 38/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
75/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DNMR
Valuation Multiples
P/E (TTM)0.0
Forward P/E0.1
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.76
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.52
Forward EPS (Est.)$6.00
Book Value / Share$0.00
Revenue / Share$0.46
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield1,666.67%
Dividend Yield0.00%
Analyst Target$0.90 (+157.1%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$0.07 |
$30.45M |
$208K |
0.7% |
| 2019 |
$-0.77 |
$32.34M |
$-19.51M |
-60.3% |
| 2020 |
$-0.18 |
$47.33M |
$-14.97M |
-31.6% |
| 2021 |
$-0.65 |
$58.75M |
$-60.11M |
-102.3% |
| 2022 |
$-1.78 |
$53.22M |
$-179.76M |
-337.8% |
| 2023 |
$-1.52 |
$46.68M |
$-155.47M |
-333% |
